Skip to Content

CREON 1236 (Creon 180,000 units amylase / 36,000 units lipase / 114,000 units protease)

Generic Name: pancrelipase

Pill with imprint CREON 1236 is Blue / Clear, Capsule-shape and has been identified as Creon 180,000 units amylase / 36,000 units lipase / 114,000 units protease. It is supplied by AbbVie, Inc..

Creon is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Creon 180,000 units amylase / 36,000 units lipase / 114,000 units protease is not a controlled substance under the Controlled Substances Act (CSA).

Images for CREON 1236

Creon

Generic Name:
pancrelipase
Imprint:
CREON 1236
Strength:
180,000 units amylase / 36,000 units lipase / 114,000 units protease
Color:
Blue / Clear
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
Digestive enzymes
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
AbbVie, Inc.
National Drug Code (NDC):
00032-3016

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide